Maravai LifeSciences Ownership | Who Owns Maravai LifeSciences?
Maravai LifeSciences Ownership Summary
Maravai LifeSciences is owned by 89.61% institutional investors, 10.16% insiders, and 0.23% retail investors. Gtcr is the largest institutional shareholder, holding 13.97% of MRVI shares. Canada Life US Small-Mid Cap Growth A is the top mutual fund, with 3.22% of its assets in Maravai LifeSciences shares.
MRVI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Maravai LifeSciences | 89.61% | 10.16% | 0.23% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Gtcr | 20.15M | 13.97% | $48.56M |
| Vanguard group | 11.82M | 8.35% | $64.43M |
| 12 west capital management lp | 11.59M | 8.19% | $63.17M |
| Blackrock | 9.73M | 7.35% | $69.66M |
| Blackrock funding, inc. /de | 9.69M | 6.72% | $23.36M |
| Braidwell lp | 8.35M | 5.79% | $20.13M |
| Mackenzie financial | 6.07M | 4.21% | $14.63M |
| Jpmorgan chase | 4.25M | 3.00% | $23.17M |
| Renaissance | 3.97M | 2.81% | $21.65M |
| Mirabella financial services llp | 3.75M | 2.60% | $9.04M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| 12 west capital management lp | 11.59M | 6.62% | $63.17M |
| Gtcr | 20.15M | 5.18% | $48.56M |
| Tejara capital | 1.94M | 2.17% | $4.68M |
| Immersion | 990.00K | 1.21% | $2.39M |
| Mirabella financial services llp | 3.75M | 0.93% | $9.04M |
| Braidwell lp | 8.35M | 0.69% | $20.13M |
| Penderfund capital management | 870.20K | 0.50% | $2.10M |
| Harspring capital management | 500.00K | 0.42% | $1.21M |
| Monaco asset management sam | 880.97K | 0.37% | $2.12M |
| Point72 (difc) | 1.56M | 0.31% | $8.48M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 9.73M | 0.00% | 3.31M |
| T. rowe price investment management | 2.64M | 0.00% | 2.64M |
| Ubs group | 1.95M | 0.00% | 1.72M |
| Tejara capital | 1.94M | 2.17% | 1.40M |
| Centerbook partners lp | 811.93K | 0.26% | 811.93K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Alyeska investment group | - | - | -5.33M |
| Jennison associates | - | - | -2.99M |
| Point72 europe (london) llp | - | - | -2.47M |
| 12 west capital management lp | 11.59M | 6.62% | -2.42M |
| Millennium management | 1.91M | 0.01% | -2.42M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| T. rowe price investment management | 2.64M | 0.00% | 2.64M | $6.37M |
| Centerbook partners lp | 811.93K | 0.26% | 811.93K | $4.42M |
| First pacific advisors, lp | 741.33K | 0.03% | 741.33K | $1.79M |
| Harspring capital management | 500.00K | 0.42% | 500.00K | $1.21M |
| Skopos labs | 138.51K | 0.04% | 138.51K | $333.80K |
Sold Out
| Holder | Change |
|---|---|
| Sjs investment consulting | -2.00 |
| Jfs wealth advisors | -5.00 |
| True wealth design | -9.00 |
| Steward partners investment advisory | -20.00 |
| Assetmark | -21.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 151 | -21.35% | 129,251,449 | 0.45% | 89 | 1.11% | 77 | -26.67% | 41 | -21.15% |
| Mar 31, 2025 | 190 | 1.60% | 128,243,066 | -8.54% | 89 | 0.91% | 103 | 11.96% | 52 | -16.13% |
| Dec 31, 2024 | 172 | -21.82% | 136,455,890 | -5.23% | 96 | 0.93% | 81 | -27.68% | 59 | -13.24% |
| Sep 30, 2024 | 220 | 6.80% | 143,991,590 | -2.29% | 101 | 0.82% | 113 | - | 68 | -1.45% |
| Jun 30, 2024 | 206 | -3.74% | 147,373,447 | 8.71% | 111 | 1.06% | 113 | 1.80% | 69 | -2.82% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Canada Life US Small-Mid Cap Growth A | 4.57M | 3.22% | - |
| Canada Life US Small-Mid Cap Growth F | 4.57M | 3.16% | - |
| Vanguard US Total Market Shares ETF | 3.94M | 2.74% | 547.00K |
| Vanguard Total Stock Mkt Idx Inv | 3.93M | 2.72% | -86.69K |
| iShares Russell 2000 ETF | 2.94M | 2.04% | -55.86K |
| Glenmede Small Cap Equity Adv | 2.03M | 1.43% | -14.85K |
| Glenmede Small Cap Equity | 2.03M | 1.43% | -14.85K |
| MFS New Discovery Value I | 2.01M | 1.42% | -28.80K |
| JPMorgan Small Cap Growth A | 1.94M | 1.35% | -21.81K |
| Jennison Health Sciences Equity | 1.70M | 1.20% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 31, 2025 | ORESHACK KURT | General Counsel | Sell | $125.75K |
| Nov 12, 2024 | DeFord John A | - | Buy | $100.63K |
| Nov 11, 2024 | HULL CARL | See Remarks | Buy | $987.00K |
| May 28, 2024 | GTCR INVESTMENT XI LLC | Sell | $97.57M | |
| Nov 25, 2020 | HULL CARL | Chief Executive Officer | Buy | $942.90K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | 1 |
| 2024 Q4 | 2 | - |
| 2024 Q3 | - | - |
MRVI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools